Cboe CA - Delayed Quote CAD
Pfizer Inc. (PFE.NE)
10.50
+0.23
+(2.24%)
At close: April 24 at 3:51:05 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
12,744,000
12,744,000
8,700,000
29,267,000
32,580,000
Investing Cash Flow
2,652,000
2,652,000
-32,278,000
-15,783,000
-22,546,000
Financing Cash Flow
-17,140,000
-17,140,000
26,066,000
-14,834,000
-9,816,000
End Cash Position
1,107,000
1,107,000
2,917,000
468,000
1,983,000
Income Tax Paid Supplemental Data
3,605,000
3,605,000
3,147,000
7,867,000
7,427,000
Interest Paid Supplemental Data
3,227,000
3,227,000
2,215,000
1,442,000
1,467,000
Capital Expenditure
-2,909,000
-2,909,000
-3,907,000
-3,236,000
-2,711,000
Issuance of Debt
8,907,000
8,907,000
38,517,000
3,891,000
997,000
Repayment of Debt
-16,066,000
-16,066,000
-2,572,000
-7,407,000
-2,100,000
Repurchase of Capital Stock
--
--
--
-2,000,000
--
Free Cash Flow
9,835,000
9,835,000
4,793,000
26,031,000
29,869,000
12/31/2021 - 12/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.44
-0.20%
LLY.NE Eli Lilly and Company
31.75
+3.66%
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
6.73
+2.75%
ABBV.NE AbbVie Inc.
25.92
+1.97%
MRK.NE Merck & Co., Inc.
18.28
+0.88%
NVS.NE NOVARTIS CDR (CAD HEDGED)
21.68
+1.17%
ROG.NE Roche Holding AG
20.82
+2.36%
NOV.SG Novo Nordisk A/S
55.39
+0.14%
JNJ0.F Johnson & Johnson
12.60
0.00%
0R34.IL Johnson & Johnson
155.60
-1.46%